©The Author(s) 2025.
World J Cardiol. Dec 26, 2025; 17(12): 112046
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112046
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112046
Figure 1 Correlations of apixaban level and Platelet Function Analyzer-200 with EXTEM clotting time.
A: The difference in apixaban levels (peak minus trough) and the difference in rotational thromboelastometry with EXTEM reagent clotting time values (post-administration minus pre-administration); B: Platelet Function Analyzer-200 assay (closure time) and the difference in rotational thromboelastometry with EXTEM reagent clotting time values (post-administration minus pre-administration) stratified by groups with and without bleeding events. Blue circles and trendlines indicate patients without bleeding events, while red circles and trendlines lines represent patients with bleeding events. CT: Clotting time.
- Citation: Bacharaki D, Kyriakou E, Sardeli A, Nikolopoulos P, Triantaphyllis G, Drakou A, Makris F, Spanou E, Triantou E, Haviaras E, Fatourou A, Poulis A, Tsantes A, Kyriazis J, Lionaki S. Bleeding prediction by rotational thromboelastometry in chronic hemodialysis patients with non-valvular atrial fibrillation on apixaban. World J Cardiol 2025; 17(12): 112046
- URL: https://www.wjgnet.com/1949-8462/full/v17/i12/112046.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i12.112046